Young rural people at risk for schizophrenia: Time for mental health services to translate research evidence into best practice of care

Australian and New Zealand Journal of Psychiatry

Volumn 44, Issue 10, 2010, Pages 872-882

  Stain, Helen J ^a,b,c,d   Clark, Scott ^a,c   O'Donnell, Maryanne ^e,f,g   Schall, Ulrich ^b,d  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

^c Greater Western Area Health Service   (Australia)

^d SCHIZOPHRENIA RESEARCH INSTITUTE   (Australia)

^e Bondi Centre   (Australia)

^f School of Psychiatry   (Australia)

^g Hunter New England Area Health Service   (Australia)

Author keywords

Adolescence; Early intervention; Psychosis; Rural mental health

Indexed keywords

OLANZAPINE; RISPERIDONE;

ANXIETY; BIPOLAR DISORDER; COGNITIVE THERAPY; DEPRESSION; DISEASE SEVERITY; FAMILY COUNSELING; HIGH RISK PATIENT; HIGH RISK POPULATION; HUMAN; LOW DRUG DOSE; MENTAL HEALTH; MENTAL HEALTH SERVICE; NERVE CELL DIFFERENTIATION; PATIENT EDUCATION; PATIENT MONITORING; PSYCHOTHERAPY; REVIEW; SCHIZOPHRENIA; SUBSTANCE ABUSE;

ADULT; EARLY DIAGNOSIS; HUMANS; MENTAL HEALTH SERVICES; PRACTICE GUIDELINES AS TOPIC; RISK; RURAL POPULATION; SCHIZOPHRENIA;

EID: 77957982180     PISSN: 00048674     EISSN: 14401614     Source Type: Journal    
DOI: 10.3109/00048674.2010.493857     Document Type: Review

References (85)

1. McGorry PD, Nelson B, Amminger GP, Bechdolf A, Francey SM, Berger G, et al. Intervention in individuals at ultra high risk for psychosis: A review and future directions J Clin Psychiatry 2009; 70:1206-1212
2. DSM-5. http://www.dsm5.org/ProposedRevisions/Revisions?Pages/ proposedrevision.aspx?rid=412
3. Morrison AP, French P, Parker S, Roberts M, Stevens H, Bentall RP, et al. Three-year follow-up of a randomized controlled trial of cognitive therapy for the prevention of psychosis in people at ultrahigh risk Schizophr Bull 2007; 33:682-687
4. Larsen TK, Melle I, Friis S, Joa I, Johannessen JO, Opjordsmoen S, et al. One-year effect of changing duration of untreated psychosis in a single catchment area British Journal of Psychiatry - Supplementum 2007; 51:S128 - 32.
5. Carr VJ, Neil AL, Halpin SA, Holmes S, Lewin TJ, Carr VJ, e t al. Costs of schizophrenia and other psychoses in urban Australia: Fi ndings from the Low Prevalence (Psychotic) Disorders Study Aust N Z J Psychiatry 2003; 37:31-40.
6. Mangalore R, Knapp M, Mangalore R, Knapp M. Cost of schizophrenia in England The Journal of Mental Health Policy & Economics 2007; 10:23-41.
7. Rund BR. A review of longitudinal studies of cognitive functions in schizophrenia patients Schizophr Bull 1998; 24:425-435
8. McGlashan TH, Hoffman RE. Schizophrenia as a disorder of developmentally reduced synaptic connectivity Arch Gen Psychiatr y 2000; 57:637-648
9. Borgwardt SJ, McGuire PK, Aston J, Berger G, Dazzan P, Gschwandtner U, et al. Structural brain abnormalities in individuals with an at-risk mental state who later develop psychosis British Journal of Psychiatry - Supplementum 2007; 51:s69 - 75.
10. Pantelis C, Velakoulis D, McGorry PD, Wood SJ, Suckling J, Phillips LJ, et al. Neuroanatomical abnormalities before and after onset of psychosis: A cross-sectional and longitudinal MRI comparison. Lancet 2003; 361:281-288
11. Sun D, Phillips L, Velakoulis D, Yung A, McGorry PD, Wood SJ, et al. Progressive brain structural changes mapped as psychosis develops in ' at risk ' individuals Schizophr Res 2009; 108:85-92.
12. Pantelis C, Yucel M, Bora E, Fornito A, Testa R, Brewer WJ, et al. Neurobiological markers of illness onset in psychosis and schizophrenia: The search for a moving target Neuropsychological Review 2009; 19:385-398.
13. Avila MT, Sherr J, Valentine LE, Blaxton TA, Thaker GK, Avila MT, et al. Neurodevelopmental interactions conferring risk for schizophrenia: A study of dermatoglyphic markers in patients and relatives Schizophr Bull 2003; 29:595-605.
14. Lloyd T, Dazzan P, Dean K, Park SB, Fearon P, Doody GA, e t al. Minor physical anomalies in patients with first-episode psychosis: Their frequency and diagnostic specifi city Psychol Med 2008; 38:71-77
15. Friston KJ, Frith CD. Schizophrenia: A disconnection syndrome? Clin Neurosci 1995; 3:89-97.
16. Bullmore ET, Frangou S, Murray RM. The dysplastic net hypothesis: An integration of developmental and dysconnectivity theories of schizophrenia Schizophr Res 1997; 28:143-156
17. Akbarian S, Kim JJ, Potkin SG, Hetrick WP, Bunney WE, Jr., Jones EG. Maldistribution of interstitial neurons in prefrontal white matter of the brains of schizophrenic patients Arch Gen Psychiatry 1996; 53:425-436
18. Levitt P, Ebert P, Mirnics K, Nimgaonkar VL, Lewis DA, Levitt P, et al. Making the case for a candidate vulnerability gene in schizophrenia: Convergent evidence for regulator of G-protein signaling 4 (RGS4) Biol Psychiatry 2006; 60:534-537
19. Cannon TD, Yolken R, Buka S, Torrey EF. Collaborative Study Group on the Perinatal Origins of Severe Psychiatric D, Cannon TD, et al. Decreased neurotrophic response to birth hypoxia in the etiology of schizophrenia Biol Psychiatry 2008; 64:797-802.
20. Geddes JR, Lawrie SM. Obstetric complications and schizophrenia: A meta-analysis Br J Psychiatry 1995; 167:786-793
21. Schmidt-Kastner R, van Os J, H WMS, Schmitz C, Schmidt- Kastner R, van Os J, et al. Gene regulation by hypoxia and the neurodevelopmental origin of schizophrenia Schizophr Res 2006; 84:253-271
22. Verdoux H, Sutter AL, Verdoux H, Sutter A-L. Perinatal risk factors for schizophrenia: Diagnostic specifi city and relationships with maternal psychopathology Am J Med Genet 2002; 114:898-905.
23. Stefansson H, Ophoff RA, Steinberg S, Andreassen OA, Cichon S, Rujescu D, et al. Common variants conferring risk of schizophrenia Nature 2009; 460:744-747
24. Brown AS, Susser ES. Prenatal nutritional defi ciency and risk of adult schizophrenia Schizophr Bull 2008; 34:1054-1063
25. McGrath J. Hypothesis: Is low prenatal vitamin D a risk-modifying factor for schizophrenia? Schizophr Res 1999; 40:173-177
26. Owen MJ, Craddock N, Jablensky A, Owen MJ, Craddock N, Jablensky A. The genetic deconstruction of psychosis Schizophr Bull 2007; 33:905-911
27. Murray RM, Lappin J, Di Forti M, Murray RM, Lappin J, Di Forti M. Schizophrenia: From developmental deviance to dopamine dysregulation Eur Neuropsychopharmacol 2008; 18 Suppl 3:S129 - 34.
28. Kapur S, Kapur S. Psychosis as a state of aberrant salience: A framework linking biology, phenomenology, and pharmacology in schizophrenia. Am J Psychiatry 2003; 160:13-23.
29. Kellendonk C, Simpson EH, Polan HJ, Malleret G, Vronskaya S, Winiger V, et al. Transient and selective overexpression of dopamine D2 receptors in the striatum causes persistent abnormalities in prefrontal cortex functioning. Neuron 2006; 49:603-615
30. Howes OD, Kapur S, Howes OD, Kapur S. The dopamine hypothesis of schizophrenia: Version III-the fi nal common pathway Schizophr Bull 2009; 35:549-562
31. Murotani T, Ishizuka T, Hattori S, Hashimoto R, Matsuzaki S, Yamatodani A, et al. High dopamine turnover in the brains of Sandy mice Neurosci Lett 2007; 421:47-51.
32. Kubota K, Kumamoto N, Matsuzaki S, Hashimoto R, Hattori T, Okuda H, et al. Dysbindin engages in c-Jun N-terminal kinase activity and cytoskeletal organization Biochem Biophys Res Commun 2009; 379:191-195
33. Jaaro-Peled H, Hayashi-Takagi A, Seshadri S, Kamiya A, Brandon NJ, Sawa A, et al. Neurodevelopmental mechanisms of schizophrenia: Understanding disturbed postnatal brain maturation through neuregulin-1-ErbB4 and DISC1 Trends Neurosci 2009; 32:485-495
34. Torrey EF, Buka S, Cannon TD, Goldstein JM, Seidman LJ, Liu T, et al. Paternal age as a risk factor for schizophrenia: How important is it? Schizophr Res 2009; 114:1-5.
35. Erlenmeyer-Kimling L. Early neurobehavioral defi cits as phenotypic indicators of the schizophrenia genotype and predictors of later psychosis Am J Med Genet 2001; 105:23-24
36. Laurens KR, Hodgins S, Maughan B, Murray RM, Rutter ML, Taylor EA, et al. Community screening for psychotic-like experiences and other putative antecedents of schizophrenia in children aged 9 - 12 years Schizophr Res 2007; 90:130-146
37. Poulton R, Caspi A, Moffi tt TE, Cannon M, Murray R, Harrington H. Children's self-reported psychotic symptoms and adult schizophreniform disorder: A 15-year longitudinal study Arch Gen Psychiatry 2000; 57:1053-1058
38. Bhugra D, Migration and schizophrenia. Acta Psychiatr Scand 2000; 102:S68 - 73.
39. Marcelis M, Navarro-Mateu F, Murray R, Selten JP, Van Os J. Urbanization and psychosis: A study of 1942 - 1978 birth cohorts in The Netherlands Psychol Med 1998; 28:871-879
40. Morgan C, Fisher H, Hutchinson G, Kirkbride J, Craig TK, Morgan K, et al. Ethnicity, social disadvantage and psychotic-like experiences in a healthy population based sample Acta Psychiatr Scand 2009; 119:226-235
41. Henquet C, Murray R, Linszen D, van Os J, Henquet C, Murray R, et al. The environment and schizophrenia: The role of cannabis use Schizophr Bull 2005; 31:608 - 12.
42. Arseneault L, Cannon M, Poulton R, Murray R, Caspi A, Moffitt TE, et al. Cannabis use in adolescence and risk for adult psychosis: Longitudinal prospective study. BMJ 2002; 325:1212-1213
43. Caspi A, Moffi tt TE, Cannon M, McClay J, Murray R, Harrington H, et al. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol- O-methyltransferase gene: Longitudinal evidence of a gene X environment interaction Biol Psychiatry 2005; 57:1117-1127
44. Henquet C, Rosa A, Krabbendam L, Papiol S, Fananas L, Drukker M, et al. An experimental study of catechol-o-methyltransferase Val158Met moderation of delta-9-tetrahydrocannabinol-induced effects on psychosis and cognition Neuropsychopharmacology 2006; 31:2748-2757
45. Walker E, Mittal V, Tessner K. Stress and the hypothalamic pituitary adrenal axis in the developmental course of schizophrenia Annual Review of Clinical Psychology 2008; 4:189-216.
46. Thompson KN, Phillips LJ, Komesaroff P, Yuen HP, Wood SJ, Pantelis C, et al. Stress and HPA-axis functioning in young people at ultra high risk for psychosis J Psychiatr Res 2007; 41:561-569
47. Thompson KN, Berger G, Phillips LJ, Komesaroff P, Purcell R, McGorry PD. HPA axis functioning associated with transition to psychosis: Combined DEX/CRH test J Psychiatr Res 2007; 41:446-450
48. Woods SW, Addington J, Cadenhead KS, Cannon TD, Cornblatt BA, Heinssen R, et al. Validity of the prodromal risk syndrome for first psychosis: Fi ndings from the North American Prodrome Longitudinal Study. Schizophr Bull 2009; 35:894-908.
49. Walker EF, Esterberg M, Brasfi eld J. The relation of cortisol secretion with social and role functioning defi cits in CHR youth Schizophr Bull 2009; 35 Supplement 1:322.
50. Cannon M, Caspi A, Moffi tt TE, Harrington H, Taylor A, Murray RM, et al. Evidence for early-childhood, pan-developmental impairment specifi c to schizophreniform disorder: Results from a longitudinal birth cohort. Arch Gen Psychiatry 2002; 59:449-456
51. Cornblatt BA, Auther AM, Cornblatt BA, Auther AM. Treating early psychosis: Who, what, and when? Dialogues Clin Neurosci 2005; 7:39-49.
52. Miller TJ, McGlashan TH, Rosen JL, Cadenhead K, Cannon T, Ventura J, et al. Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: Predictive validity, interrater reliability, and training to reliability[erratum appears in Schizophr Bull. 2004;30(2):following 217]
53. Schizophr Bull 2003; 29:703-715
54. Yung AR, Yuen HP, McGorry PD, Phillips LJ, Kelly D, Dell'Olio M, et al. Mapping the onset of psychosis: The Comprehensive Assessment of At-Risk Mental States Aust N Z J Psychiatry 2005; 39:964-971
55. Van Os J, Delespaul P, Van Os J, Delespaul P. Toward a world consensus on prevention of schizophrenia Dialogues Clin Neurosci 2005; 7:53-67.
56. Klosterkotter J, Hellmich M, Steinmeyer EM, Schultze-Lutter F. Diagnosing schizophrenia in the initial prodromal phase. Arch Gen Psychiatry 2001; 58:158-164
57. Amercian Psychiatric Association. www.psych.org
58. McGorry PD, McGorry PD. Issues for DSM-V: Clinical staging: A heuristic pathway to valid nosology and safer, more effective treatment in psychiatry Am J Psychiatry 2007; 164:859-860
59. Schizophrenia Research Forum. www.schizophreniaforum.org
60. Carpenter WT, Carpenter WT. Anticipating DSM-V: Should psychosis risk become a diagnostic class? Schizophr Bull 2009; 35:841-843
61. French P, Shryane N, Bentall RP, Lewis SW, Morrison AP. Effects of cognitive therapy on the longitudinal development of psychotic experiences in people at high risk of developing psychosis British Journal of Psychiatry - Supplementum 2007; 51:s82 - 7.
62. Miller TJ, Zipursky RB, Perkins D, Addington J, Woods SW, Hawkins KA, et al. The PRIME North America randomized doubleblind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. II. Baseline characteristics of the "prodromal" sample Schizophr Res 2003; 61:19-30. (Pubitemid 36332136)
63. Marshall M, Rathbone J. Early intervention for psychosis. [update of Cochrane Database Syst Rev. 2004;(2):CD004718; PMID: 15106257]
64. Cochrane Database Syst Rev 2006:CD004718.
65. Morrison AP, French P, Walford L, Lewis SW, Kilcommons A, Green J, et al. Cognitive therapy for the prevention of psychosis in people at ultra-high risk: Randomised controlled trial. Br J Psychiatry 2004; 185:291-297
66. McGlashan TH, Zipursky RB, Perkins D, Addington J, Miller T, Woods SW, et al. Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis. Am J Psychiatry 2006; 163:790-799
67. McGorry PD, Yung AR, Phillips LJ, Yuen HP, Francey S, Cosgrave EM, et al. Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms Arch Gen Psychiatry 2002; 59:921-928
68. Amminger GP, Schafer MR, Papageorgiou K, Klier CM, Cotton SM, Harrigan SM, et al. Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: A randomized, placebocontrolled trial Arch Gen Psychiatry 2010; 67:146-154
69. Birchwood M, Patterson P, Lester H, Singh S. Integrating UHR research and practice into the public health agenda: The Birmingham ED:IT programme Schizophr Bull 2009; 35 Supplement 1:S134 - 135.
70. Lewis SW, Wykes T, David A, Marshall M, Deakin W, Szmukler G. The UK Mental Health Research Network: Large scale trials for non-drug interventions for schizophrenia Schizophr Bull 2009; 35 Supplement 1:134.
71. NHS. Schizophrenia clinical guidelines London: National Institute for Health and Clinical Excellence, 2009.
72. Mental Health Research Network. www.mhrn.info/index.html
73. Mihalopoulos C, Harris M, Henry L, Harrigan S, McGorry P, Mihalopoulos C, et al. Is early intervention in psychosis costeffective over the long term? Schizophr Bull 2009; 35:909-918
74. Stain HJ, Crittenden K, Bennett E, Startup M, Carr V, Baker A, et al. The impact of geography and social context on ultra high risk for schizophrenia research in rural Australia Schizophr Bull 2009; 35 Supplement 1:S376 - 377.
75. McGlashan TH, Addington J, Cannon T, Heinimaa M, McGorry P, O'Brien M, et al. Recruitment and treatment practices for helpseeking "prodromal" patients Schizophr Bull 2007; 33:715-726
76. Yung AR, Phillips LJ, Yuen HP, McGorry PD, Yung AR, Phillips LJ, et al. Risk factors for psychosis in an ultra high-risk group: Psychopathology and clinical features Schizophr Re s 2004; 67:131-142
77. Bechdolf A, Phillips LJ, Francey SM, Leicester S, Morrison AP, Veith V, et al. Recent approaches to psychological interventions for people at risk of psychosis Eur Arch Psychiatry Clin Neurosc i 2006; 256:159-173
78. Weiser M, van Os J, Reichenberg A, Rabinowitz J, Nahon D, Kravitz E, et al. Social and cognitive functioning, urbanicity and risk for schizophrenia Br J Psychiatry 2007; 191:320-324
79. AIHW. Rural, regional and remote health. Mortality trends 1992 - 2003. Rural Health Series No.7 Cat No. PHE 71. Canberra: Australian Institute of Health and Welfare , 2006.
80. Page A, Morrell S, Taylor R, Dudley M, Carter G, Page A, e t al. Further increases in rural suicide in young Australian adults: Secular trends, 1979 - 2003 Soc Sci Me d 2007; 65:442-453
81. Australian Institute of Health and Welfare., Y oung Australians: Their health and well-being 2007 Cat no PHE 87 2007.
82. Griffi ths KM, Christensen H, Jorm AF, Griffi ths KM, Christensen H, Jorm AF. Mental health literacy as a function of remoteness of residence: An Australian national study BMC Public Health 2009; 9:92.
83. Hafner H, Maurer K, Ruhrmann S, Bechdolf A, Klosterkotter J, Wagner M, et al. Early detection and secondary prevention of psychosis: Facts and visions Eur Arch Psychiatry Clin Neurosci 2004; 254:117-128
84. McGorry PD, Yung AR, Bechdolf A, Amminger P, McGorry PD, Yung AR, et al. Back to the future: Predicting and reshaping the course of psychotic disorder. Arch Gen Psychiatr y 2008; 65:25-27
85. Nelson B, Simmons MB, Yung AR, Buckby JA, O'Dwyer L, Francey SM, et al. Identifying the ultra-high risk (prodromal) population: Evaluation of training workshops with mental health services Aust N Z J Psychiatry 2008; 42:236-243